Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Prendiville

Showing results (61-70 of 83) with videos related to

Pageof 9
Sort By:
Journal of Vascular Surgery|July 1, 1992
The profunda femoris: a durable outflow vessel in aortofemoral surgeryE J Prendiville, P E Burke, M P Colgan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 1998
Randomized phase II trial of infusional fluorouracil, epirubicin, and cyclophosphamide versus infusional fluorouracil, epirubicin, and cisplatin in patients with advanced breast cancerT Eisen, I E Smith, S Johnston, et al.
Journal of Animal Science|July 1, 1997
Effects of suppressing cortisol following castration of bull calves on adrenocorticotropic hormone, in vitro interferon-gamma production, leukocytes, acute-phase proteins, growth, and feed intakeA D Fisher, M A Crowe, E M O'Nualláin, et al.
European Journal of Vascular Surgery|June 1, 1991
Increased in-vitro incubation time of endothelial cells on fibronectin-treated ePTFE increases cell retention in blood flowE J Prendiville, J E Coleman, A D Callow, et al.
British Journal of Cancer|October 1, 1994
Establishment of a murine leukaemia cell line resistant to the growth-inhibitory effect of bryostatin 1J Prendiville, A T McGown, A Gescher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1995
High complete remission rates with primary neoadjuvant infusional chemotherapy for large early breast cancerI E Smith, G Walsh, A Jones, et al.
Journal of Animal Science|September 1, 1993
Effects of growth hormone-releasing factor and(or) thyrotropin-releasing hormone on growth, feed efficiency, carcass characteristics, and blood hormones and metabolites in beef heifersW J Enright, D J Prendiville, L J Spicer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 1993
A randomised dose intensity study in ovarian carcinoma comparing chemotherapy given at four week intervals for six cycles with half dose chemotherapy given for twelve cyclesD Murphy, D Crowther, J Renninson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 24, 1997
A prospective randomised trial of protracted venous infusion 5-fluorouracil with or without mitomycin C in advanced colorectal cancerP Ross, A Norman, D Cunningham, et al.
British Journal of Cancer|August 1, 1995
A phase I trial of bryostatin 1 in patients with advanced malignancy using a 24 hour intravenous infusionG C Jayson, D Crowther, J Prendiville, et al.
Pageof 9

Showing results (61-70 of 83) with videos related to

Sort By:
Pageof 9
Journal of Vascular Surgery|July 1, 1992
The profunda femoris: a durable outflow vessel in aortofemoral surgeryE J Prendiville, P E Burke, M P Colgan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 1998
Randomized phase II trial of infusional fluorouracil, epirubicin, and cyclophosphamide versus infusional fluorouracil, epirubicin, and cisplatin in patients with advanced breast cancerT Eisen, I E Smith, S Johnston, et al.
Journal of Animal Science|July 1, 1997
Effects of suppressing cortisol following castration of bull calves on adrenocorticotropic hormone, in vitro interferon-gamma production, leukocytes, acute-phase proteins, growth, and feed intakeA D Fisher, M A Crowe, E M O'Nualláin, et al.
European Journal of Vascular Surgery|June 1, 1991
Increased in-vitro incubation time of endothelial cells on fibronectin-treated ePTFE increases cell retention in blood flowE J Prendiville, J E Coleman, A D Callow, et al.
British Journal of Cancer|October 1, 1994
Establishment of a murine leukaemia cell line resistant to the growth-inhibitory effect of bryostatin 1J Prendiville, A T McGown, A Gescher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1995
High complete remission rates with primary neoadjuvant infusional chemotherapy for large early breast cancerI E Smith, G Walsh, A Jones, et al.
Journal of Animal Science|September 1, 1993
Effects of growth hormone-releasing factor and(or) thyrotropin-releasing hormone on growth, feed efficiency, carcass characteristics, and blood hormones and metabolites in beef heifersW J Enright, D J Prendiville, L J Spicer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 1993
A randomised dose intensity study in ovarian carcinoma comparing chemotherapy given at four week intervals for six cycles with half dose chemotherapy given for twelve cyclesD Murphy, D Crowther, J Renninson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 24, 1997
A prospective randomised trial of protracted venous infusion 5-fluorouracil with or without mitomycin C in advanced colorectal cancerP Ross, A Norman, D Cunningham, et al.
British Journal of Cancer|August 1, 1995
A phase I trial of bryostatin 1 in patients with advanced malignancy using a 24 hour intravenous infusionG C Jayson, D Crowther, J Prendiville, et al.
Pageof 9